Clear Street LLC increased its stake in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Free Report) by 6,942.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,592 shares of the company’s stock after purchasing an additional 8,470 shares during the period. Clear Street LLC owned 0.15% of Bellevue Life Sciences Acquisition worth $92,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Condor Capital Management bought a new stake in shares of Bellevue Life Sciences Acquisition during the fourth quarter worth $121,000. Warberg Asset Management LLC lifted its position in Bellevue Life Sciences Acquisition by 47.1% during the 2nd quarter. Warberg Asset Management LLC now owns 39,781 shares of the company’s stock valued at $429,000 after purchasing an additional 12,741 shares during the period. Berkley W R Corp bought a new position in shares of Bellevue Life Sciences Acquisition in the 1st quarter valued at about $3,440,000. Finally, K2 Principal Fund L.P. acquired a new stake in shares of Bellevue Life Sciences Acquisition during the 1st quarter worth approximately $358,000. Institutional investors and hedge funds own 55.30% of the company’s stock.
Bellevue Life Sciences Acquisition Price Performance
BLAC opened at $10.89 on Thursday. Bellevue Life Sciences Acquisition Corp. has a 52 week low of $10.39 and a 52 week high of $11.60. The company has a fifty day moving average price of $10.84 and a two-hundred day moving average price of $10.77.
Bellevue Life Sciences Acquisition Profile
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington.
Featured Articles
- Five stocks we like better than Bellevue Life Sciences Acquisition
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Stocks to Neutralize Market Volatility and Build Wealth
- Learn Technical Analysis Skills to Master the Stock Market
- How Much Can You Make in Stocks in One Month?
- Why Invest in 5G? How to Invest in 5G Stocks
- This Is the Top Large-Cap Stock Insiders Are Buying
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.